Overview
- 8 FDA inspections are on record.
- 2 inspections produced a Form 483.
- The most recent recorded inspection date is 2017-12-13.
At a glance
Inspections
8
Form 483s
2
EIRs
0
Last outcome
Clean
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 13 Dec 2017 | Human Drugs | Clean | |
| 24 Mar 2016 | Foods & Cosmetics | Clean | |
| 29 Jul 2011 | Not recorded | Clean | |
| 17 Feb 2010 | Not recorded | 483 | View 483 → |
| 25 Sep 2008 | Not recorded | 483 | On file |
| 14 Jan 2005 | Not recorded | Clean | |
| 13 Feb 2002 | Not recorded | Clean | |
| 3 May 2001 | Not recorded | Clean |
Observations on record
Form 483 observations cited at this site, most recent first.
Investigators
FDA investigators tied to this site in the record.
Andrew J Barrowcliff1 insp.
Alexandra A Carrico1 insp.
Robert M Barbosa1 insp.
David A Paterson1 insp.
Rebecca E Dombrowski1 insp.
Daniel J Brown1 insp.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.80(a) | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Martin Ekwealor Pharmaceuticals, Inc.'s 2 Form 483s
Verbatim observations and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat